학술논문
Single-dose of adrecizumab versus placebo in acute cardiogenic shock (ACCOST-HH): an investigator-initiated, randomised, double-blinded, placebo-controlled, multicentre trial
Document Type
Article
Author
Karakas, Mahir ; Akin, Ibrahim; Burdelski, Christoph; Clemmensen, Peter; Grahn, Hanno; Jarczak, Dominik; Keßler, Mirjam; Kirchhof, Paulus; Landmesser, Ulf; Lezius, Susanne; Lindner, Diana; Mebazaa, Alexandre; Nierhaus, Axel; Ocak, Anil; Rottbauer, Wolfgang; Sinning, Christoph; Skurk, Carsten; Söffker, Gerold; Westermann, Dirk; Zapf, Antonia; Zengin, Elvin; Zeller, Tanja; Kluge, Stefan
Source
In The Lancet Respiratory Medicine March 2022 10(3):247-254
Subject
Language
ISSN
2213-2600